Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all- trans retinoic acid

British Journal of Haematology

Volumn 108, Issue 4, 2000, Pages 696-702

  Kitamura, Kunio ^a   Hoshi, Shinetsu ^b   Koike, Mitsuru ^c   Kiyoi, Hitoshi ^a   Saito, Hidehiko ^a   Naoe, Tomoki ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Kamaishi Municipal Hospital   (Japan)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute promyelocytic leukaemia; All trans retinoic acid; Arsenic trioxide; Differentiation; Histone deacetylase inhibitor

Indexed keywords

ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HISTONE DEACETYLASE INHIBITOR; RETINOIC ACID; UNCLASSIFIED DRUG;

AGED; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CASE REPORT; CELL DIFFERENTIATION; FEMALE; GENE TRANSLOCATION; HUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ARSENICALS; CELL DIFFERENTIATION; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 17; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FEMALE; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; OXIDES; TRANSLOCATION, GENETIC; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0034030355     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.01933.x     Document Type: Article

References (41)

1. Borrow, J., Goddard, A.D., Sheer, D. & Solomon, E. (1990) Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science, 249, 1577-1580.
2. 3 induces NB4 cell apoptosis with downregulation of BcI-2 expression and modulation of PML-RARα/PML proteins. Blood, 88, 1052-1061.
3. 3 exerts dose-dependent dual effects on APL cells. Blood, 89, 3345-3353.
4. Chen, S.-J., Zelent, A., Tong, J.-H., Yu, H.-Q., Wang, Z.-Y., Derré, J., Berger, R., Waxman, S. & Chen, Z. (1993) Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t (11; 17) (q23: q21) in a patient with acute promyelocytic leukemia. Journal of Clinical Investigation, 91, 2260-2267.
5. Chen, Z., Brand, N.J., Chen, A., Chen, S.-J., Tong, J.-H., Wang, Z.-Y., Waxman, S. & Zelent, A. (1993) Fusion between a novel Krüppel-like zinc finger gene and the retinoic acid receptor-α locus due to a variant t (11; 17) translocation associated with acute promyelocytic leukemia. EMBO Journal, 12, 1161-1167.
6. Culligan, D.J., Stevenson, D., Chee, Y.-L. & Grimwade, D. (1998) Acute promyelocytic leukaemia with t (11; 17) (q23: q12-21) and a good initial response to prolonged ATRA and combination chemotherapy. British Journal of Haematology, 100, 328-330.
7. Degos, L., Dombret, H., Chomienne, C., Daniel, M.-T., Miclea, J.-M., Chastang, C., Castaigne, S. & Fenaux, P. (1995) All-trans retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood, 85, 2643-2653.
8. Gianni, M., Koken, M., Chelbi-Alix, M., Benoit, G., Lanotte, M., Chen, Z. & de The, H. (1998) Combined arsenic and retinoic acid treatment enhances differentiation and apoptosis in arsenic-resistant NB4 cells. Blood, 91, 4300-4310.
9. Grignani, F., Matteis, S.D., Nervi, C., Tomassoni, L., Gelmetti, V., Cioce, M., Fanelli, M., Ruthardt, M., Ferrara, F.F., Zamir, I., Seiser, C., Grignani, F., Lazar, M.A., Minucci, S. & Pelicci, P.G. (1998) Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia. Nature, 391, 815-818.
10. Guidez, F., Huang, W., Tong, J.-H., Dubois, C., Balitrand, N., Waxman, S., Michaux, J.L., Martiat, P., Degos, L., Chen, Z. & Chomienne, C. (1994) Poor response to all-trans retinoic acid therapy in a t (11; 17) PLZF/RARα patient. Leukemia, 8, 312-317.
11. Guidez, F., Ivins, S., Zhu, J., Söderström, M., Waxman, S. & Zelent, A. (1998) Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML-and PLZF-RARα underlie molecular pathogenesis and treatment of acute promyelocytic leukemia. Blood, 91, 2634-2642.
12. He, L.Z., Guidez, F., Tribioli, C., Peruzzi, D., Ruthardt, M., Zelent, A. & Pandolfi, P.P. (1998) Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL. Nature Genetics, 18, 126-135.
13. Hoshi, S. (1999) Acute promyelocytic leukemia with t (11; 17) (q23; q21 ); a case report. Japanese Journal of Clinical Hematolagy, 40, 119-123.
14. Huang, M.E., Ye, Y.C., Chen, S.R., Chai, J.R., Lu, J.X., Zhoa, L., Gu, L.J. & Wang, Z.Y. (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood, 72, 567-572.
15. Jansen, J.H., de Ridder, M.C., Geertsma, W.M.C., Erpelinck, C.A.J., van Lom, K., Smit, E.M.E., Slater, R., vd Reijden, B.A., de Greef, G.E., Sonneveld, P. & Lowenberg, B. (1999) Complete remission of t (11; 17) positive acute promyelocytic leukemia induced by all-trans retinoic acid and granulocyte colony-stimulating factor. Blood, 94, 39-45.
16. Kijima, M., Yoshida, M., Sugita, K., Horinouchi, S. & Beppu, T. (1993) Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase. Journal of Biological Chemistry, 268, 22429-22435.
17. 3+) and other metal ions on acute promyelocytic leukemia cells. International Journal of Hematology, 65, 179-185.
18. Kitamura, K., Kiyoi, H., Yoshida, H., Saito, H., Ohno, R. & Naoe, T. (1997b) Mutant AF-2 domain of PML-RARα in retinoic acid-resistant NB4 cells: differentiation induced by RA is triggered directly through PML-RARα and its down-regulation in acute promyelocytic leukemia. Leukemia, 11, 1950-1956.
19. Koken, M.H.M., Daniel, M.-T., Gianni, M., Zelent, A., Licht, J., Buzyn, A., Minard, P., Degos, L., Varet, B. & de The, H. (1999) Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARα fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant 1 (11; 17) (q23; q21) APL patient. Oncogene, 18, 1113-1118.
20. Kosugi, H., Towatari, M., Hatano, S., Kitamura, K., Kiyoi, H., Kinoshita, T., Tanimoto, M., Murate, T., Kawashima, K., Saito, H. & Naoe, T. (1999) Histone deacetylase inhibitors are potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy. Leukemia, 13, 1316-1324.
21. Lallemand-Breitenbach, V., Guillemin, M.-C., Janin, A., Daniel, M.-T., Degos, L., Kogan, S.C., Bishop, J.M. & de Thé, H. (1999) Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia. Journal of Experimental Medicine, 189, 1043-1052.
22. Licht, J.D., Chomienne, C., Goy, A., Chen, A., Scott, A.A., Head, D.R., Michaux, J.L., Wu, Y., DeBlasio, A., Miller, W.H., Zelenetz, A.D., Willman, C.L., Chen, Z., Chen, S.-J., Zelent, A., Macintyre, E., Veil, A., Cortes, J., Kantarjian, H. & Waxman, S. (1995) Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11; 17). Blood, 85, 1083-1094.
23. Lin, R.J., Nagy, L., Inoue, S., Shao, W., Miller, W.H. & Evans, R.M. (1998) Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature, 391, 811-814.
24. Melnick, A. & Licht, J.D. (1999) Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood, 93, 3167-3215.
25. Nakajima, H., Kim, Y.B., Terano, H., Yosida, M. & Horinouchi, S. (1998) FR901228, a potent antitumor antibiotic, is a novel historic deacetylase inhibitor. Experimental Cell Research, 241, 126-133.
26. Raelson, J.V., Nervi, C., Rosenauer, A., Benedetti, L., Monczak, Y., Pearson, M., Pelicci, P.G. & Miller, W.H. (1996) The PML/RARα oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells. Blood, 88, 2826-2832.
27. Redner, R.L., Rush, E.A., Faas, S., Rudert, W.A. & Corey, SJ. (1996) The t (5; 17) variant of acute promyelocytic leukemia expresses a nucleoplasmin-retinoic acid receptor fusion. Blood, 87, 882-886.
28. 3) in the treatment of acute promyelocytic leukemia (APL). II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood, 89, 3354-3360.
29. Sitterlin, D., Tiollais, P. & Transy, C. (1997) The RARγ-PLZF chimera associated with acute promyelocytic leukemia has retained a sequence-specific DNA-binding domain. Oncogene, 14, 1067-1074.
30. Soignet, S.L., Maslak, P., Wang, Z.G., Jhanwar, S., Calleja, E., Dardashti, L.J., Corso, D., DeBlasio, A., Gabrilove, J., Scheinberg, D.A., Pandolti, P.P. & Warrell, R.P. (1998) Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. New England Journal of Medicine, 339, 1341-1348.
31. Sternsdorf, T., Puccetti, E., Jensen, K., Hoelzer, D., Will, H., Ottmann, O.G. & Ruthardt, M. (1999) PIC-1 /SUMO-1-modified PML-retinoic acid receptor a mediates arsenic trioxide-induced apoptosis in acute promyelocytic leukemia. Molecular and Cellular Biology., 19, 5170-5178.
32. de Thé, H., Chomienne, C., Lanotte, M., Degos, L. & Dejean, A. (1990) The t (15; 17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor-alpha gene to a novel transcribed locus. Nature, 347, 558-561.
33. Ueda, H., Manda, T., Matsumoto, S., Mukumoto, S., Nishigaki, F., Kawamura, I. & Simomura, K. (1994) FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum no. 968. III. Antitumor activities on experimental tumors in mice. Journal of Antibiotics, 47, 315-323.
34. Warrell, R.P., de Thé, H., Wang, Z.Y. & Degos, L. (1993) Acute promyelocytic leukemia. New England Journal of Medicine, 329, 177-189.
35. VVarrell, R.P., He, L.Z., Richon, V., Calleja, E. & Pandolfi, P.P. (1998) Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. Journal of the National Cancer Institute, 90, 1621-1625.
36. Wells, R.A., Catzavelos, C. & Kamel-Reid, S. (1997) Fusion of retinoic acid receptor α to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukemia. Nature Genetics, 17, 109-113.
37. Yoshida, M., Kijima, M., Akita, M. & Beppu, T. (1990) Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by tricostatin A. Journal of Biological Chemistry, 265, 17174-17179.
38. Yoshida, M., Horinouchi, S. & Beppu, T. (1995) Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays, 17, 423-430.
39. Yoshida, H., Kitamura, K., Tanaka, K., Omura, S., Miyazaki, T., Hachiya, T., Ohno, R. & Naoe, T. (1996) Accelerated degradation of PML-retinoic acid receptor a (PML-RARA) oncoprotein by all-trans retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway. Cancer Research, 56, 2945-2948.
40. Zelent, A. (1994) Translocation of the RARα locus to the PML, or PLZF gene in acute promyelocytic leukaemia. British Journal of Haematology, 86, 451-460.
41. Zhu, J., Marcel, H., Koken, M.H., Quignon, F., Chelbi-Alix, M.K., Degos, L., Wang, Z.Y., Chen, Z. & de The, H. (1997) Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia. Proceedings of the National Academy Sciences of the United States of America, 94, 3978-3983.